Literature DB >> 15389824

Dysplastic changes in the peripheral blood of children with microdeletion 22q11.2.

Namik Ozbek1, Murat Derbent, Lale Olcay, Zerrin Yilmaz, Kürşat Tokel.   

Abstract

Myelodysplasia refers to abnormal morphology of the bone marrow and/or peripheral blood. This condition is frequently due to myelodysplastic syndrome; however, myelodysplasia is caused by a variety of factors and is not always a sign of pre-malignant disease. We observed myelodysplastic changes in peripheral blood smears and bone marrow specimens from a patient who had chromosomal microdeletion 22q11.2 (del22q11.2). We then investigated such changes in several other patients who were newly diagnosed with del22q11.2 (n = 5 total, including the index case) and compared the findings to those in four sets of controls without this chromosomal abnormality. Specifically, the controls were children with conotruncal heart defects (n = 3); otherwise healthy children with bacterial (n = 4) or viral infection (n = 4); and healthy children (n = 4). The myelodysplasia scores in the myeloid cells and eosinophils of the children with del22q11 were higher than those in all four of the control groups. Myelodysplastic changes in the peripheral blood of children with del22q11.2 have not been reported previously. We believe that certain gene(s) in the deleted region may be responsible for the myelodysplastic changes that we observed in our patients with this chromosomal abnormality. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 15389824     DOI: 10.1002/ajh.20139

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

Review 1.  Congenital neutropenia: diagnosis, molecular bases and patient management.

Authors:  Jean Donadieu; Odile Fenneteau; Blandine Beaupain; Nizar Mahlaoui; Christine Bellanné Chantelot
Journal:  Orphanet J Rare Dis       Date:  2011-05-19       Impact factor: 4.123

2.  A child with psoriasis, hypogammaglobulinemia, and monosomy 7-positive myelodysplastic syndrome.

Authors:  Namık Özbek; Arzu Yazal Erdem; Özlem Arman Bilir; Fatma Karaca Kara; Mutlu Yüksek; Neşe Yaralı; Meltem Özgüner; Nazmiye Yüksek; Bahattin Tunç
Journal:  Turk J Haematol       Date:  2015-03-05       Impact factor: 1.831

3.  Risk of malignancy in 22q11.2 deletion syndrome.

Authors:  Toer Stevens; Jutte van der Werff Ten Bosch; Marjan De Rademaeker; Ann Van Den Bogaert; Machiel van den Akker
Journal:  Clin Case Rep       Date:  2017-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.